EQUINE SAFETY ZONE’s predecessor, ARDA (Army Research and Development Activity), later ARDA-MEDCO, was started 18 years ago to RESEARCH combat-related medical problems and DEVELOP solutions that would be effective even under the most unimaginable conditions.
In 1991, ARDA-19 was tested and approved by the Surgeon General for use by all branches of the Armed Services and all federal agencies and was issued a Federal Contract by the Department of Defense.
Subsequently, 49 variations of ARDA-19 were formulated and tested resulting in a master, patented formulation of six d distinct antimicrobial agents that can be manipulated to attack and destroy the specific organisms responsible for disease conditions in horses. Ninety-nine percent of these organisms are killed on contact with any of our products – EVEN when we dilute our product down to 1:32,000. Independent Laboratory testing was used and is availabl, to substantiate this claim. Our chief formulation chemist has been issued 63 US patents in antimicrobial chemistry (available upon request) and has coordinated the prosecution and maintenance of a roster of 300 US patents and trademarks.
Equine Dermatological Problems
“Skin disease in horses can be singularly distressing to many owners and so it is not surprising that if we, as animal health professionals, fail to solve problems, owners resort to often unproved and even harmful remedies to treat their horses. This frequently leads to a clinical deterioration and often an alteration in the clinical appearance of the condition. It can become increasingly difficult to reach either a definitive diagnosis or a successful outcome.” '
1. Pascoe RRR and Knottenbelt D.C. (1999) Preface. IN: Manual of Equine Dermatology. WB Saunders Philadelphia, pp. Preface.
• Any antimicrobial will have some limited effect on a bacterial or fungal cause of dermatological pathology.
• Many commercially available over-the-counter antimicrobial preparations have mild to extremely harmful and painful side effects.
• One company stands alone in their approach to solving dermatological problems in horses—our philosophy becomes our science and our science ultimately becomes our product.
Our Philosophy
• Identify a skin disease syndrome and the causative organism(s)
• Review the literature, historical treatments, and current products available used to treat a specific problem
• Evaluate what is being done to treat a disease and the mechanisms involved in trying to effect a “cure”
• Analyze the side effects of any given treatment
Only then, if we can
RESOLVE the condition better, faster, safer, do we set about to create a product without side affects or clinical deterioration or alterations of the clinical appearance of the condition.
ResolveA19 for rainrot, ringworm, and thrush in their final form exceeded even our expectations.